Product Information

KETOCONAZOLE 2% FOAM is a generic product labeled by Xiromed LLC, priced at $5.7451 per GM under NDC 70700016019. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on May 21, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

KETOCONAZOLE 2% FOAM

Ketoconazole Foam
$5.7451per GM

Strength

20 mg/g

Manufacturer

Xiromed LLC

NDC

70700016019

Classification

Generic

Dosage Form

AEROSOL, FOAM

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

KETOCONAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA213601

FDA Approved

5/21/2021

TE Code

AB

On Market Since

5/21/2021

Pharmacological Classes

Azole Antifungal
Azoles
Cytochrome P450 3A4 Inhibitors
Cytochrome P450 3A5 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for KETOCONAZOLE 2% FOAM has been published 136 times since Apr 17, 2024, and over the history we have for it it has declined 13.9%. The table below summarizes its recorded NADAC range and movement.

Current price$5.7451 per GM
All-time high$8.0876 (Dec 11, 2024)
All-time low$5.2798 (Dec 17, 2025)
52-week high$6.3867
52-week low$5.2798
Median price$6.3631
Average price$6.3617
Largest weekly change+9.2% (Nov 20, 2024)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

+2.2%

1M

+2.6%

3M

+0.9%

6M

-4.2%

1Y

+8.0%

3Y

N/A

5Y

N/A

All

-13.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 37%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETOCONAZOLE 2% FOAM?

The current National Average Drug Acquisition Cost (NADAC) for KETOCONAZOLE 2% FOAM, manufactured by Xiromed LLC, is $5.7451 per GM (NDC 70700016019), effective Nov 18, 2026.

How has the price of KETOCONAZOLE 2% FOAM changed over time?

Over the history we have for it, the NADAC for KETOCONAZOLE 2% FOAM has declined 13.9%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for KETOCONAZOLE 2% FOAM?

Since Apr 17, 2024, the NADAC for KETOCONAZOLE 2% FOAM has ranged from a low of $5.2798 (Dec 17, 2025) to a high of $8.0876 (Dec 11, 2024), with a median of $6.3631 per GM.

Are there cheaper alternatives to KETOCONAZOLE 2% FOAM?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOCONAZOLE 2% FOAM, is $3.6470 per GM — about 37% below KETOCONAZOLE 2% FOAM.

Who manufactures KETOCONAZOLE 2% FOAM?

KETOCONAZOLE 2% FOAM (NDC 70700016019) is labeled by Xiromed LLC, and CMS classifies it as a generic product.